Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial

PURPOSE: Local/systemic symptoms during cancer therapy may be exacerbated by dysregulated inflammation and its downstream toxic effects. Minocycline can suppress proinflammatory cytokine release; therefore, we investigated its potential to reduce patient-reported symptom severity during radiotherapy...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Support Care Cancer
Egile Nagusiak: Gunn, G. Brandon, Mendoza, Tito R., Garden, Adam S., Wang, Xin Shelley, Shi, Qiuling, Morrison, William H., Frank, Steven J., Phan, Jack, Fuller, Clifton D., Chambers, Mark S., Hanna, Ehab Y., Lu, Charles, Rosenthal, David I., Cleeland, Charles S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470188/
https://ncbi.nlm.nih.gov/pubmed/31037378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-04791-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak